Skip to main content
Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

Publisher: Bentham Science Publishers

More about this publication?
Volume 1, Number 1, 2005

Review article

Favourites:
ADD

RNA Interference: A New Targeted Tumour Therapy?
pp. 11-17(7)
Authors: Withey, Jane M.E.; Crompton, Mark R.

Favourites:
ADD

Therapeutic Strategies for Papillary Microcarcinoma of the Thyroid
pp. 19-25(7)
Authors: Ito, Yasuhiro; Miyauchi, Akira

Favourites:
ADD

EBV-Associated Tumors: Pathogenetic Insights for Improved Disease Monitoring and Treatment
pp. 27-44(18)
Authors: Dolcetti, Riccardo; Guidoboni, Massimo; Gloghini, Annunziata; Carbone, Antonino

Favourites:
ADD

Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications
pp. 45-50(6)
Authors: Lesslie III, Donald P.; Gallick, Gary E.

Favourites:
ADD

Membrane Receptor and Antiangiogenic Targeted Therapies in the Treatment of Cancer
pp. 51-61(11)
Authors: Jimeno, Antonio; Cortes-Funes, HernĂ¡n

Favourites:
ADD

New Approaches to Postoperative Radiotherapy for Cancer of the Head and Neck
pp. 63-70(8)
Authors: Prellop, Perri; Ove, Roger

Favourites:
ADD

The Role of Chemokines and their Receptors in Tumor Progression and Invasion: Potential New Targets of Biological Therapy
pp. 81-92(12)
Authors: Allavena, Paola; Marchesi, Federica; Mantovani, Alberto

Favourites:
ADD

Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor
pp. 93-108(16)
Authors: Trent, Jonathan C.; Dupart, Jheri; Zhang, Wei

Favourites:
ADD

Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment
pp. 109-114(6)
Authors: Fujiki, Hirota; Suganuma, Masami; Matsuyama, Satoru; Miyazaki, Kohji

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content